MyYSM

63 results

Rate Search Results

News
Making a Mark: Local Vaccine Trial Taking Personal Approach to Treating Kidney Cancer
When it comes to treating and beating cancer, the same approach doesn’t always work for every patient.
Source: WFSB Eyewitness News (with Dr. David Braun)
14 Mar 2025
News
Therapeutic vaccine for kidney cancer provided positive results in study
In Friday’s Health headlines, it’s kidney cancer awareness month. As we raise awareness about the disease, a new Yale-led study involving a personalized therapeutic vaccine provided positive results for patients. Dr. David Braun, a medical oncologist and researcher at Yale Cancer Center, joined WTNH's Good Morning Connecticut at 9 a.m. to discuss.
Source: WTNH News 8 (with Dr. David Braun)
14 Mar 2025
News
YCC Publications 2025
Publications regarding cancer attributed to first- and last-authors of published papers
9 Mar 2025
News
Study Identifies Specific Immune Features that Could Be Targeted to Improve Cancer Treatment
Cancer Discovery
26 Feb 2025
News
New kidney cancer vaccine puts 9 advance-stage patients into remission
An early-phase trial found that a personalized vaccine targeted and destroyed cancer cells in nine patients with advanced kidney cancer, effectively wiping out the disease and keeping it at bay.
Source: New York Post (with David Braun, MD, PhD)
26 Feb 2025
News
Yale doctor's cancer vaccine puts nine patients into remission in groundbreaking study
A cancer 'vaccine' developed by a Yale University scientist kept people's kidney cancer from recurring for three years, marking a major milestone in highly personalized cancer care.
Source: Daily Mail Online (with Yale's Dr. David Braun)
24 Feb 2025
News
Experimental cancer vaccine shows promising results for certain patients
Experimental vaccine reduced chances of kidney cancer recurrence.
Source: New York Post
13 Feb 2025
News
Cancer vaccine shows promising results for certain patients
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.
Source: Fox News
12 Feb 2025
News
Health Rounds: Vaccine keeps advanced kidney cancer from recurring (with Dr. David Braun)
"We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively 'steered' towards the cancer in a very specific way," study co-author Dr. David Braun of Yale School of Medicine in New Haven, Connecticut said in a statement.
Source: Reuters
7 Feb 2025
News
BioNTech’s oncology vaccine trial sees all patients living kidney cancer-free
Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping cancer.
Source: Yahoo
6 Feb 2025
News
Therapeutic Vaccine May Fight Advanced Kidney Cancer
The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their tumors, explained a team led by Dr. David Braun of the Yale Cancer Center in New Haven, Conn.
Source: HealthDay
6 Feb 2025
News
New Vaccine Shows Promise For Kidney Cancer
“This approach is truly distinct from vaccine attempts in kidney cancer," said David A. Braun, MD, PhD first author of the paper in a press release. “We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively “steered” towards the cancer in a very specific way. We learned which specific targets in the cancer are most susceptible to immune attack and demonstrated that this approach can generate long-lasting immune responses, directing the immune system to recognize cancer,” added Braun.
Source: Forbes
6 Feb 2025
News
Personalized Therapeutic Vaccine ‘Steers’ the Immune System to Fight Kidney Cancer
Vaccines are on the cutting edge of cancer therapy research as a possible treatment option for the future. The trial led by Yale Cancer Center (YCC) principal investigator and first author David Braun, MD, PhD, explored the effectiveness of the personalized cancer vaccine specifically for patients with advanced kidney cancer — stage III or IV clear cell renal cell carcinoma.
5 Feb 2025
News
Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Source: STAT News
5 Feb 2025
News
ASCI Welcomes 5 New Members from YSM
The American Society for Clinical Investigation honors new members for translational research excellence.
14 Jan 2025
News
New Study Unveils Clues to ‘Exceptional’ Response in Metastatic Kidney Cancer Immunotherapy
Yale Cancer Center researchers uncovered factors behind why some patients may respond better to certain immunotherapy treatments.
9 Jan 2025
News
Yale Cancer Center Expert Receives Kidney Cancer Association's Rising Star Award
David Braun, MD, PhD, assistant professor of medicine (medical oncology), pathology, and urology at Yale School of Medicine and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, received the Christopher G. Wood Rising Star Award by the Kidney Cancer Association at the 2024 International Kidney Cancer Symposium in Louisville, KY.
5 Nov 2024
News
Dr Braun on the Role of Biomarkers in Guiding Adjuvant Treatment for RCC
David A. Braun, MD, PhD, assistant professor, medical oncology, Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center, discusses the role of biomarkers in optimizing adjuvant treatment strategies for renal cell carcinoma (RCC).
Source: OncLive
11 Sep 2024
News
Dr. David Braun on Yale Cancer Answers
Dr. David Braun on Yale Cancer Answers.
12 Aug 2024
News
Yale Cancer Center Researchers and Trainees Present at ASCO
Yale Cancer Center scientists and trainees attended the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago May 31-June 4 to present research advances from Yale Cancer Center and Smilow Cancer Hospital. The ASCO meeting is the most significant gathering of oncology professionals worldwide, initiating connections and forging collaborations that can change the landscape of cancer care.
7 Jun 2024